Stocks · News reference

Exelixis Lowers FY2026 Sales Guidance from $2.525B-$2.625B to $2.500B-$2.550B vs $2.595B Est

Aug 5, 2026, 8:23 PMBenzinga Newsdesk

Exelixis (NASDAQ:EXEL) lowers FY2026 sales outlook from $2.525 billion-$2.625 billion to $2.500 billion-$2.550 billion vs $2.595 billion estimate.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 19, 2026, 10:32 AMBenzinga Newsdesk
BMO Capital Initiates Coverage On Exelixis with Market Perform Rating, Announces Price Target of $54
BMO Capital analyst David Lebowitz initiates coverage on Exelixis (NASDAQ:EXEL) with a Market Perform rating and announces Price Target of $54.
Read original at benzinga
EXEL
BenzingaAug 6, 2026, 4:00 PMBenzinga Newsdesk
Truist Securities Maintains Hold on Exelixis, Lowers Price Target to $52
Truist Securities analyst Gregory Renza maintains Exelixis (NASDAQ:EXEL) with a Hold and lowers the price target from $56 to $52.
Read original at benzinga
EXEL
BenzingaAug 6, 2026, 2:17 PMBenzinga Newsdesk
Stifel Maintains Hold on Exelixis, Raises Price Target to $51
Stifel analyst Stephen Willey maintains Exelixis (NASDAQ:EXEL) with a Hold and raises the price target from $47 to $51.
Read original at benzinga
EXEL
BenzingaAug 6, 2026, 11:29 AMBenzinga Newsdesk
Exelixis shares are trading lower after the company reported mixed Q2 financial results and cut its FY26 sales guidance below estimates.
Read original at benzinga
EXEL